MAPK3 and cancer: The relationship between miRNA-145 and ERK1/2 in general appears to be inverse; indeed ERK1/2 inhibited miRNA-145 expression in human aortic SMC [42] and miRNA-145 inhibition reportedly enhanced ERK1/2 and Akt phosphorylation in cancer cells [43].